InvestorGain adds Buybacks & Authorizations, Secondary Offerings, New Issues & Calendars, Blogs, and Education coverage that Stock Analysis skips.
VOL. XCIV, NO. 247
★ FINANCIAL TOOLS & SERVICES DIRECTORY ★
PRICE: 5 CENTS
Monday, October 6, 2025
Head-to-head
InvestorGain vs Stock Analysis comparison
Compare pricing, supported platforms, categories, and standout capabilities to decide which tool fits your workflow.
Quick takeaways
Stock Analysis includes Screeners, ETF Screeners, Top Analysts, Stock Comparison, ETF Comparison, Portfolio, Watchlist, News, Dividends, Splits, Delisted, Spin-offs, Ticker Changes, Acquisitions, Bankruptcy, Financials, ETF Overview, ETF Holdings, ETF Fundamentals, and ETF Performance categories that InvestorGain omits.
InvestorGain highlights: Live IPO GMP dashboard for mainboard & SME issues, incl. Kostak and estimated listing price (cap price + GMP)., Real‑time IPO subscription tracker with category splits (RII, NII, QIB) for current issues., and IPO anchor investor allocation reports by year (mainboard & SME)..
Stock Analysis is known for: Stock, ETF, and IPO screeners with 200+ indicators and real-time filtering. Pro users can save screens., Coverage spans more than 100,000 tradable symbols worldwide. US quotes are real-time via Cboe; international quotes are delayed or EOD depending on exchange., and Financial data provided by S&P Global. Free users see 5 years of history; Pro extends to 10 years. Downloadable exports use Nasdaq Data Link (US) and FMP (non-US)..
InvestorGain
investorgain.com
India‑focused IPO & primary‑markets portal with live IPO subscription tracking, Grey Market Premium (GMP) dashboards, anchor investor allocations, and new‑issue calendars (NCDs, SGBs, rights). Provides broker reviews/comparisons and free brokerage calculators. GMP is expressly noted as based on market perception/public sources; the site states it does not work with GMP operators and content is for education/news. The business is ad/affiliate‑supported.
Categories
Platforms
Pricing
Quick highlights
- Live IPO GMP dashboard for mainboard & SME issues, incl. Kostak and estimated listing price (cap price + GMP).
- Real‑time IPO subscription tracker with category splits (RII, NII, QIB) for current issues.
- IPO anchor investor allocation reports by year (mainboard & SME).
- IPO performance history and GMP‑vs‑actual listing performance trackers.
- Rights issues dashboard (record date, entitlement, pricing, timelines).
Community votes (overall)
Stock Analysis
stockanalysis.com
A comprehensive equity and ETF research platform. The free site includes screeners, comparisons, corporate actions, and market calendars. The Pro plan unlocks unlimited CSV/Excel downloads, saved screeners, advanced analyst filters, full ETF holdings, and longer financial history. US quotes are real-time via Cboe, while international quotes are delayed or end-of-day. Financials come from S&P Global Market Intelligence, with 5 years shown free and 10 years on Pro.
Categories
Platforms
Pricing
Quick highlights
- Stock, ETF, and IPO screeners with 200+ indicators and real-time filtering. Pro users can save screens.
- Coverage spans more than 100,000 tradable symbols worldwide. US quotes are real-time via Cboe; international quotes are delayed or EOD depending on exchange.
- Financial data provided by S&P Global. Free users see 5 years of history; Pro extends to 10 years. Downloadable exports use Nasdaq Data Link (US) and FMP (non-US).
- Pro plan includes unlimited CSV/Excel exports, advanced analyst filtering, business metrics for 40,000+ companies, detailed ETF holdings, and full corporate actions. Pricing: $6.58/month (annual) or $9.99/month (monthly).
- Watchlists double as a portfolio tracker, showing holdings, P/L, cash, and currencies. Supports real-time price updates and CSV/Excel exports.
Community votes (overall)
Shared focus areas
2 overlapsMutual strengths include IPO, and Calendar.
Where they differ
InvestorGain
Distinct strengths include:
- Live IPO GMP dashboard for mainboard & SME issues, incl. Kostak and estimated listing price (cap price + GMP).
- Real‑time IPO subscription tracker with category splits (RII, NII, QIB) for current issues.
- IPO anchor investor allocation reports by year (mainboard & SME).
- IPO performance history and GMP‑vs‑actual listing performance trackers.
Stock Analysis
Distinct strengths include:
- Stock, ETF, and IPO screeners with 200+ indicators and real-time filtering. Pro users can save screens.
- Coverage spans more than 100,000 tradable symbols worldwide. US quotes are real-time via Cboe; international quotes are delayed or EOD depending on exchange.
- Financial data provided by S&P Global. Free users see 5 years of history; Pro extends to 10 years. Downloadable exports use Nasdaq Data Link (US) and FMP (non-US).
- Pro plan includes unlimited CSV/Excel exports, advanced analyst filtering, business metrics for 40,000+ companies, detailed ETF holdings, and full corporate actions. Pricing: $6.58/month (annual) or $9.99/month (monthly).
Feature-by-feature breakdown
Attribute | InvestorGain | Stock Analysis |
---|---|---|
Categories Which research workflows each platform targets | Shared: IPO, Calendar Unique: Buybacks & Authorizations, Secondary Offerings, New Issues & Calendars, Blogs, Education | Shared: IPO, Calendar Unique: Screeners, ETF Screeners, Top Analysts, Stock Comparison, ETF Comparison, Portfolio, Watchlist, News, Dividends, Splits, Delisted, Spin-offs, Ticker Changes, Acquisitions, Bankruptcy, Financials, ETF Overview, ETF Holdings, ETF Fundamentals, ETF Performance |
Asset types Supported asset classes and universes | Stocks, Bonds | Stocks, ETFs, Mutual Funds |
Experience levels Who each product is built for | Beginner, Intermediate, Advanced | Beginner, Intermediate, Advanced |
Platforms Where you can access the product | Web, Mobile | Web, Mobile |
Pricing High-level pricing models | Free | Free, Subscription |
Key features Core capabilities called out by each vendor | Unique
| Unique
|
Tested Verified by hands-on testing inside Find My Moat | Not yet | Yes |
Editor pick Featured inside curated shortlists | Standard listing | Highlighted |
Frequently Asked Questions
Which workflows do InvestorGain and Stock Analysis both support?
Both platforms cover IPO, and Calendar workflows, so you can research those use cases in either tool before digging into the feature differences below.
Do InvestorGain and Stock Analysis require subscriptions?
Both InvestorGain and Stock Analysis keep freemium access with optional paid upgrades, so you can trial each platform before committing.
How can you access InvestorGain and Stock Analysis?
Both InvestorGain and Stock Analysis support web and mobile access, making it easy to keep tabs on research away from the desk.
What unique strengths set the two platforms apart?
InvestorGain differentiates itself with Live IPO GMP dashboard for mainboard & SME issues, incl. Kostak and estimated listing price (cap price + GMP)., Real‑time IPO subscription tracker with category splits (RII, NII, QIB) for current issues., and IPO anchor investor allocation reports by year (mainboard & SME)., whereas Stock Analysis stands out for Stock, ETF, and IPO screeners with 200+ indicators and real-time filtering. Pro users can save screens., Coverage spans more than 100,000 tradable symbols worldwide. US quotes are real-time via Cboe; international quotes are delayed or EOD depending on exchange., and Financial data provided by S&P Global. Free users see 5 years of history; Pro extends to 10 years. Downloadable exports use Nasdaq Data Link (US) and FMP (non-US)..
Keep exploring
Stay on top of related tools
Browse the categories and profiles that overlap most with this comparison to round out your shortlist.
Related categories
Follow the same themes these tools compete in.
Recommended tools
These profiles share overlapping coverage with both sides of this matchup.
- Seeking AlphaEditor's pickHands-on review
Overlap: Screeners, ETF Screeners, and Stock Comparison.
ScreenersETF ScreenersStock Comparison - Stock RoverEditor's pickHands-on review
Overlap: Screeners, ETF Screeners, and Stock Comparison.
ScreenersETF ScreenersStock Comparison - TipRanksEditor's pickHands-on review
Overlap: Top Analysts, Screeners, and ETF Screeners.
Top AnalystsScreenersETF Screeners - KoyfinEditor's pickHands-on review
Overlap: Screeners, ETF Screeners, and News.
ScreenersETF ScreenersNews - Investing.comHands-on review
Overlap: Screeners, ETF Screeners, and Portfolio.
ScreenersETF ScreenersPortfolio - Yahoo FinanceHands-on review
Overlap: Screeners, Watchlist, and Portfolio.
ScreenersWatchlistPortfolio
Curation & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.